A new study from researchers at Wake Forest University School of Medicine shows that only 3.5 years of intensive blood ...

Intensive blood pressure control for adults with hypertension and high cardiovascular risk can reduce the risk of mild ...

The US Food and Drug Administration (FDA) has approved Eisai and Biogen’s Supplemental Biologics License Application for once ...

Q. Two members of our book group have early signs of cognitive impairment. We have become so close after 10 years of being ...

"If you look at all the things we know that may be associated with the risk of developing dementia, the two strongest are age ...

Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatment Alzheimer's ...

Wake Forest University School of Medicine researchers found that just 3½ years of intensive blood pressure control can significantly reduce the risk of mild cognitive impairment or dementia.

Mild and reversible AKI was tied to an increased risk for probable dementia and mild cognitive impairment in older adults ...

“Our study shows that intensive blood pressure control is an important strategy in the prevention of cognitive impairment, a ...

Biogen (BIIB) and Eisai announced an update on the ongoing regulatory review of the Marketing Authorization Application for lecanemab as ...

A new study shows that only 3½ years of intensive blood pressure control continues to significantly reduce the risk of mild ...